Capricor Therapeutics, Inc.
Status: Publicly traded
Direct answer
Capricor Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CAPR.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on pioneering transformative cell and exosome-based therapies to treat and prevent a diverse range of diseases and disorders. Their lead therapeutic, CAP-1002, is an allogeneic cell therapy derived from heart tissue. This candidate has successfully completed its Phase III clinical trial for patients afflicted with late-stage Duchenne...
Can you invest in Capricor Therapeutics, Inc.?
Yes. Capricor Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CAPR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Capricor Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.